Gallbladder Cancer Symptoms, Doctors, Treatments, Advances & More

Learn About Gallbladder Cancer

What is the definition of Gallbladder Cancer?

A benign or malignant neoplasm affecting the gallbladder. Representative examples of benign neoplasms include lipoma, leiomyoma, and neurofibroma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma.

Save information for later

What are the alternative names for Gallbladder Cancer?

Gallbladder cancer

What are the different types of Gallbladder Cancer?

Common conditions include: Gallbladder Adenocarcinoma

Who are the top Gallbladder Cancer Local Doctors?

Dr. Timothy L. Cannon

Oncology | Hematology Oncology | Hematology

Advanced

Highly rated in

conditions

Oncology
Hematology Oncology
Hematology

Inova

Hematology Oncology - Fair Oaks

3580 Joseph Siewick Dr,

Fairfax, VA

12.6 mi

Timothy Cannon is an Oncologist and a Hematologist Oncology doctor in Fairfax, Virginia. Dr. Cannon has been practicing medicine for over 18 years and is rated as an Advanced doctor by MediFind in the treatment of Gallbladder Cancer. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Pancreatoblastoma, Colorectal Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer. Dr. Cannon is currently accepting new patients.

Dr. Grace C. Yang

Family Medicine

Advanced

Highly rated in

conditions

Family Medicine

Walk-In Clinic

610 Solarex Ct,

Frederick, MD

24.5 mi

Grace Yang is a Family Medicine doctor in Frederick, Maryland. Dr. Yang has been practicing medicine for over 25 years and is rated as an Advanced doctor by MediFind in the treatment of Gallbladder Cancer. She is also highly rated in 2 other conditions, according to our data. Her top areas of expertise are Gallbladder Cancer, Gallbladder Adenocarcinoma, Autoimmune Hemolytic Anemia, and Neurosarcoidosis. Dr. Yang is currently accepting new patients.

Learn about our expert tiers

Learn more

Dr. Emily R. Winslow

General Surgery | Surgical Oncology

Advanced

Highly rated in

conditions

General Surgery
Surgical Oncology

MedStar Health

MedStar Georgetown University Hospital

3800 Reservoir Rd Nw,

Washington, DC

24.2 mi

Emily Winslow is a General Surgeon and a Surgical Oncologist in Washington, Washington, D.c.. Dr. Winslow has been practicing medicine for over 24 years and is rated as an Advanced doctor by MediFind in the treatment of Gallbladder Cancer. She is also highly rated in 13 other conditions, according to our data. Her top areas of expertise are Hepatic Hemangioma, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Gastrectomy, and Small Bowel Resection. Dr. Winslow is currently accepting new patients.

View All Doctors

What are the latest Gallbladder Cancer Clinical Trials?

A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers

Who is this study for: Patients with Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma

Enrollment Status: Recruiting

Publish Date: April 05, 2023

Intervention Type: Procedure, Drug, Biological

Study Drugs: AtezolizumabCobimetinibVarlilumab

Study Phase: Phase 2

Summary: This phase II trial investigates the effect of combining two immune therapies, atezolizumab and CDX-1127 (varlilumab), with or without cobimetinib, in treating patients with biliary tract cancer that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

Match to trials

Find the right clinical trials for you in under a minute

Get started

A Multicenter, Open-label, Phase 2 Basket Study of MK-7684A, a Co-formation of Vibostolimab (MK-7684) With Pembrolizumab (MK-3475), With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors

Who is this study for: Patients with selected solid tumors

Enrollment Status: Recruiting

Publish Date: April 04, 2023

Intervention Type: Drug, Biological

Study Drugs: PembrolizumabVibostolimabLenvatinib5-FluorouracilCisplatinPaclitaxelGemcitabineCarboplatinDocetaxelBevacizumabCapecitabineOxaliplatin

Study Phase: Phase 2

Summary: The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of pembrolizumab/vibostolimab co-formulation (MK-7684A) with or without other anticancer therapies in participants with selected advanced solid tumors. The primary hypothesis is that pembrolizumab/vibostolimab co-formulation is superior to pembrolizumab alone in terms of objective response rate or progress...

View All Clinical Trials

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Gallbladder Cancer?